# Redpin Therapeutics, Inc. — Form D

Redpin Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-09. The offering totals $30.0M, of which $7.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-03-09
- Form: D
- Accession: 0001735933-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $7.8M
- Remaining: $22.2M
- Investors: 8
- Date of first sale: 2020-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-362277

## Issuer

- Name: Redpin Therapeutics, Inc.
- CIK: 0001735933
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1392 MADISON AVENUE, NEW YORK, NY, 10029
- Phone: 9179719655

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Elma Hawkins | Director | Brooklyn, NY |
| Elma Hawkins | Executive Officer | Brooklyn, NY |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-03-29](https://search.stillhousedata.com/formd/0001735933-18-000001) | D | $5.0M | $1.5M |

## More

- [CIK 1735933 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735933&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001735933-20-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.